EOM Pharmaceutical Holdings Inc (IMUC)
0.1979
+0.02
(+12.16%)
USD |
OTCM |
Apr 19, 15:28
EOM Pharmaceutical Holdings Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | -2.113M |
| April 17, 2024 | -2.224M |
| April 16, 2024 | -2.023M |
| April 15, 2024 | -2.257M |
| April 12, 2024 | -2.257M |
| April 11, 2024 | -2.257M |
| April 10, 2024 | -2.303M |
| April 09, 2024 | -2.216M |
| April 08, 2024 | -1.935M |
| April 05, 2024 | -2.391M |
| April 04, 2024 | -2.022M |
| April 03, 2024 | -2.022M |
| April 02, 2024 | -2.056M |
| April 01, 2024 | -2.215M |
| March 28, 2024 | -2.215M |
| March 27, 2024 | -2.085M |
| March 26, 2024 | -1.888M |
| March 25, 2024 | -1.704M |
| March 22, 2024 | -1.704M |
| March 21, 2024 | -1.93M |
| March 20, 2024 | -1.93M |
| March 19, 2024 | -1.930M |
| March 18, 2024 | -1.926M |
| March 15, 2024 | -1.779M |
| March 14, 2024 | -1.846M |
| Date | Value |
|---|---|
| March 13, 2024 | -1.636M |
| March 12, 2024 | -1.804M |
| March 11, 2024 | -1.796M |
| March 08, 2024 | -2.048M |
| March 07, 2024 | -1.804M |
| March 06, 2024 | -1.846M |
| March 05, 2024 | -1.972M |
| March 04, 2024 | -1.972M |
| March 01, 2024 | -1.645M |
| February 29, 2024 | -1.624M |
| February 28, 2024 | -1.853M |
| February 27, 2024 | -1.632M |
| February 26, 2024 | -1.595M |
| February 23, 2024 | -1.595M |
| February 22, 2024 | -1.595M |
| February 21, 2024 | -1.804M |
| February 20, 2024 | -1.804M |
| February 16, 2024 | -1.620M |
| February 15, 2024 | -1.636M |
| February 14, 2024 | -1.636M |
| February 13, 2024 | -1.636M |
| February 12, 2024 | -1.636M |
| February 09, 2024 | -1.804M |
| February 08, 2024 | -1.595M |
| February 07, 2024 | -1.595M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.391M
Minimum
Apr 05 2024
1.215M
Maximum
Feb 16 2021
-1.196M
Average
-1.469M
Median
Aug 30 2019
Enterprise Value Benchmarks
| CEL-SCI Corp | 77.73M |
| AIM ImmunoTech Inc | 11.42M |
| IGC Pharma Inc | 29.10M |
| NovaBay Pharmaceuticals Inc | 2.485M |
| Protalix BioTherapeutics Inc | 58.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3067M |
| Total Expenses (Quarterly) | 0.3071M |
| EPS Diluted (Quarterly) | -0.01 |